Steven Pieper
Chief Financial Officer · 4 filings · Latest: Aug 12, 2026
Xeris Biopharma Holdings, Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
XERS | Steven Pieper | Chief Financial Officer | Aug 12, 2026 | Sale | $8.50 | 5,000 | $42.5K | 1,361,053 | |
XERS | STEVEN PIEPER | — | Aug 12, 2026 | Proposed Sale | $8.39 | 20,000 | $167.8K | — | |
XERS | Steven Pieper | Chief Financial Officer | Jul 7, 2026 | Sale | $8.52 | 27,600 | $235.3K | 1,366,053 | |
XERS | Steven Pieper | Chief Financial Officer | Jul 6, 2026 | Sale | $8.50 | 17,400 | $147.9K | 1,393,653 | |
XERS | STEVEN PIEPER | — | Jul 7, 2026 | Proposed Sale | $8.37 | 27,600 | $231.0K | — | |
XERS | STEVEN PIEPER | — | Jul 6, 2026 | Proposed Sale | $8.28 | 17,400 | $144.1K | — | |
XERS | Steven Pieper | Chief Financial Officer | Mar 5, 2026 | Option Exercise | $4.71 | 41,927 | $197.3K | 1,408,940 |